These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. Mata I, Rodríguez-Sánchez JM, Pelayo-Terán JM, Pérez-Iglesias R, González-Blanch C, Ramírez-Bonilla M, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B. Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495 [Abstract] [Full Text] [Related]
28. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert? Bang M, Kim KR, Song YY, Baek S, Lee E, An SK. Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742 [Abstract] [Full Text] [Related]
29. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder. Vaskinn A, Sundet K, Simonsen C, Hellvin T, Melle I, Andreassen OA. Neuropsychology; 2011 Jul; 25(4):499-510. PubMed ID: 21463042 [Abstract] [Full Text] [Related]
30. The relative contribution of neurocognition and social cognition to 6-month vocational outcomes following Individual Placement and Support in first-episode psychosis. Allott KA, Cotton SM, Chinnery GL, Baksheev GN, Massey J, Sun P, Collins Z, Barlow E, Broussard C, Wahid T, Proffitt TM, Jackson HJ, Killackey E. Schizophr Res; 2013 Oct; 150(1):136-43. PubMed ID: 23938175 [Abstract] [Full Text] [Related]
31. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum. Kontaxaki MI, Kattoulas E, Smyrnis N, Stefanis NC. Psychiatriki; 2014 Oct; 25(1):27-38. PubMed ID: 24739500 [Abstract] [Full Text] [Related]
32. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry PD. Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204 [Abstract] [Full Text] [Related]
33. Impact of duration of untreated psychosis and premorbid intelligence on cognitive functioning in patients with first-episode schizophrenia. Wang MY, Ho NF, Sum MY, Collinson SL, Sim K. Schizophr Res; 2016 Aug; 175(1-3):97-102. PubMed ID: 27146474 [Abstract] [Full Text] [Related]
34. Neurocognitive growth charting in psychosis spectrum youths. Gur RC, Calkins ME, Satterthwaite TD, Ruparel K, Bilker WB, Moore TM, Savitt AP, Hakonarson H, Gur RE. JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990 [Abstract] [Full Text] [Related]
35. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Becker HE, Nieman DH, Wiltink S, Dingemans PM, van de Fliert JR, Velthorst E, de Haan L, van Amelsvoort TA, Linszen DH. Psychol Med; 2010 Oct; 40(10):1599-606. PubMed ID: 20132582 [Abstract] [Full Text] [Related]
36. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression. Hill SK, Keshavan MS, Thase ME, Sweeney JA. Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687 [Abstract] [Full Text] [Related]
37. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia. Kake TR, Garrett N, Te Aonui M. Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850 [Abstract] [Full Text] [Related]
38. Neurocognition and recovery in first episode psychosis. Faber G, Smid HG, Van Gool AR, Wunderink L, Wiersma D, van den Bosch RJ. Psychiatry Res; 2011 Jun 30; 188(1):1-6. PubMed ID: 21122926 [Abstract] [Full Text] [Related]
39. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S. Encephale; 2003 Jun 30; 29(3 Pt 1):266-72. PubMed ID: 12876552 [Abstract] [Full Text] [Related]
40. Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible? González-Blanch C, Priede A, Rodríguez-Sánchez JM, Perez-Iglesias R, Vázquez-Barquero JL, Crespo-Facorro B. Compr Psychiatry; 2012 Aug 30; 53(6):701-5. PubMed ID: 22206803 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]